Patents Assigned to GENE SIGNAL SAS
  • Publication number: 20100135985
    Abstract: The invention pertains to the area of pharmaceutical compositions that are useful for treating pathologies resulting from a deregulation of the angiogenesis mechanism. The invention particularly concerns new genes whose function had not been identified before now as well as genes that are known but whose involvement in the angiogenesis mechanism has been shown for the first time.
    Type: Application
    Filed: January 10, 2006
    Publication date: June 3, 2010
    Applicant: GENE SIGNAL SAS
    Inventors: Sylvie Colin, Salman Al-Mahmood